section name header

Basics

[Section Outline]

Author:

Neal P.O'Connor


Description!!navigator!!

Etiology!!navigator!!

Diagnosis

[Section Outline]

Signs and Symptoms!!navigator!!

History

  • Previous episodes: Raise concern for CA-MRSA
  • Immunosuppression
  • Medications:
    • Chronic steroids, chemotherapy
  • IVDU
  • History of mammalian bite

Physical Exam

  • Location and extent of infection
  • Presence of:
    • Associated cellulitis
    • Subcutaneous air
    • Deep structure involvement
  • Involvement of specialty area:
    • Perirectal
    • Hand
    • Face/neck

Essential Workup!!navigator!!

Diagnostic Tests & Interpretation!!navigator!!

Lab

  • Routine lab tests are not typically indicated.
  • Glucose determination may be useful if:
    • Underlying undiagnosed diabetes is a concern
    • There is a concern for associated diabetic ketoacidosis (DKA)
  • For febrile patients who appear septic, systemically ill, or have recent IVDU the following labs are indicated:
    • Blood cultures
    • Lactate
    • Renal function
    • CK if myositis suspected

Imaging

  • Bedside US can be helpful in distinguishing cellulitis from abscess especially in equivocal cases
  • CT/MRI can be helpful in determining deep tissue involvement
  • Plain films may reveal gas in tissue planes

Differential Diagnosis!!navigator!!

Treatment

[Section Outline]

Prehospital!!navigator!!

Caution: Septic patients may require rapid transport with IV access and volume resuscitation

Initial Stabilization/Therapy!!navigator!!

Septic patient:

ED Treatment/Procedures!!navigator!!

Pediatric Considerations
Incision and drainage are painful procedures that often require procedural sedation and analgesia

Medication!!navigator!!

ALERT
  • Know your local susceptibility patterns
  • Oral antibiotics (moderate associated cellulitis):
    • Amoxicillin/clavulanate:
      • Use: Mammalian bites/MSSA/Strep species
      • Adult dose: 500-875 mg (peds: 40-80 mg/kg/d div q12h) PO q12h
    • TMP-SMX:
      • Use: MRSA
      • Adult dose: 160/800 mg (peds: 4-5 mg/kg) PO BID
    • Clindamycin:
      • Use: MRSA
      • Adult dose: 300-450 mg (peds: 4-8 mg/kg) PO q6h
    • Doxycycline:
      • Use: MRSA
      • Adult dose: 100 mg (peds: over 8 yr: 1.1 mg/kg) PO q12h
    • Cephalexin:
      • Use: MSSA/Strep species
      • Adult dose: 250 mg PO q6h or 500 mg PO q12h (peds: 25-50 mg/kg/d div q12h)
    • Erythromycin:
      • Use: MSSA/Strep species
      • Adult dose: 250-500 mg (peds: 10 mg/kg) PO q6-8h
  • IV antibiotics (systemic illness or extensive associated cellulitis):
    • Ampicillin/sulbactam
      • Uses: Human/mammalian bites and facial cellulitis
      • Adult dose: 1.5-3 g (peds: <40 kg, 75 mg/kg; 40 kg, adult dose) IV q6h (max = 12 g/d)
    • Vancomycin:
      • Use: MRSA
      • Adult dose: 15 mg/kg IV q12h (peds: 10-15 mg/kg/d div q6-8 h) (max = 2,000 mg/d)
    • Daptomycin:
      • Use MRSA
      • Adult dose: 4 mg/kg IV q24h
    • Linezolid:
      • Use: MRSA
      • Adult dose: 600 mg IV/PO q12h (peds: 30 mg/kg/d div q8h)
    • Clindamycin:
      • Use: MRSA
      • Adult dose: 600 mg (peds: 10-15 mg/kg) IV q8h

Follow-Up

[Section Outline]

Disposition!!navigator!!

In accordance with abscess type and severity of infection

Admission Criteria

  • Sepsis/systemic illness
  • Immunocompromised host with moderate/large cellulitis
  • Perirectal involvement
  • Any abscess requiring incision and debridement in the operating room

Discharge Criteria

Most patients with uncomplicated abscesses can be treated with incision and drainage and close follow-up

Follow-up Recommendations!!navigator!!

Pearls and Pitfalls

  • Consider CA-MRSA in recurrent abscesses
  • Pain control is essential during incision and drainage of abscesses
  • Beware of tenosynovitis and deep fascial space infections

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9

ICD10

SNOMED